Analysis of antithrombotic therapy prescription for the prevention of stroke and systemic embolism in patients with atrial fibrillation in clinical practice

被引：0
|
作者：
Linchak, R. [1 ]
Komkov, D. [1 ]
机构：
[1] Natl Res Ctr Prevent Med, Moscow, Russia
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6261
引用
收藏
页码：1112 / 1112
页数：1
相关论文
共 50 条
  • [1] Prescription and adherence patterns of antithrombotic therapy for the secondary prevention of stroke in patients with atrial fibrillation
    Sanchez-Saez, Francisco
    Riera-Arnau, Judit
    Hurtado-Navarro, Isabel
    Rodriguez-Bernal, Clara
    Sanfelix-Gimeno, Gabriel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 21 - 21
  • [2] Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan
    Maruhashi, Tatsuya
    Higashi, Yukihito
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2115 - 2124
  • [3] Antithrombotic therapy for stroke prevention in atrial fibrillation
    Go, AS
    Fang, MC
    Singer, DE
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 48 (02) : 108 - 124
  • [4] Update on antithrombotic therapy for stroke prevention in atrial fibrillation
    Abcede H.G.
    Ovbiagele B.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2010, 12 (3) : 250 - 260
  • [5] Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice
    An, JaeJin
    Niu, Fang
    Lang, Daniel T.
    Jazdzewski, Kristin P.
    Le, Paul T.
    Rashid, Nazia
    Meissner, Brian
    Mendes, Robert
    Dills, Diana G.
    Aranda, Gustavus, Jr.
    Bruno, Amanda
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (07):
  • [6] Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Karly P. Garnock-Jones
    [J]. Drugs & Aging, 2011, 28 : 415 - 419
  • [7] Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Garnock-Jones, Karly P.
    [J]. DRUGS & AGING, 2011, 28 (05) : 415 - 419
  • [8] APIXABAN IN THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN NONVALVULAR ATRIAL FIBRILLATION
    Pujadas-Mestres, L.
    Escolar, G.
    Arellano-Rodrigo, E.
    Galan, A. M.
    [J]. DRUGS OF TODAY, 2013, 49 (07) : 425 - 436
  • [9] Challenges of stroke prevention in patients with atrial fibrillation in clinical practice
    Hobbs, F. D. Richard
    Leach, I.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2011, 104 (09) : 739 - 746
  • [10] A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    LaHaye, Stephen Andrew
    Gibbens, Sabra Lynn
    Ball, David Gerald Andrew
    Day, Andrew George
    Olesen, Jonas Bjerring
    Skanes, Allan Cameron
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (17) : 2163 - 2171
12345